March's pick of media campaigns
Footcare expert Scholl has teamed up with The College of Podiatry, the professional body for the UK’s HCPC registered Podiatrists, to raise awareness of foot health and to help educate healthcare professionals and the UK public on how to care for their feet.
The venture comes as a result of recent Pharmaceutical Journal research, which explored the challenges that pharmacy healthcare professionals face when supporting the UK public’s foot health.
Although 62 per cent of UK pharmacists surveyed saw foot conditions in practice at least once a month, only 7 percent of them said they were very confident diagnosing dermatological foot conditions and just 5 per cent felt the same about non-dermatological foot complaints.
A package of footcare-tailored assets, including a diagnostic tool and in-depth clinical professional development module, will be developed by Scholl and the College of Podiatry.
Clarinaze Allergy Control Nasal Spray The launch of the POM to P switch, Clarinaze once daily nasal spray, is being supported with a £1 million marketing campaign to include a full suite of pharmacy training, instore shopper activation, as well as a digital consumer media campaign.
Clarinaze is the only mometasone product available without prescription, and is designed to prevent and relieve perennial allergy symptoms including sneezing, a runny, stuffy, or itchy nose. It gets to work within 12 hours and can be used up to two days before the start of the pollen season.
Clarinaze Nasal Spray is available in an 18g pump (equivalent to 140 sprays), RRP £13.99.
Bayer Consumer Health 0118 206 3000
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.